Our Regulatory Affairs department is committed to guiding our clients through the regulatory processes of both the EU and US markets, by providing support in CE marking or the FDA submission process.
With extensive expertise spanning various therapeutic areas, developmental phases, and industries and a deep understanding of regulatory environments, we help clients bring their IVD diagnostic kits to market confidently.
Ensuring compliance with relevant regulations such as the FDA in the US, the CE directive in the EU, and other national or international regulatory frameworks.
Conducting thorough evaluations of risks associated with IVD diagnostic kits, including patient health risks, result accuracy, and user safety.
Validating manufacturing, assembly, and quality control processes to ensure reliability and reproducibility of IVD kit results.
Collaborating with clients to monitor and participate in clinical studies to assess IVD kit performance, including sensitivity, specificity, and diagnostic accuracy
Ensuring compliance with relevant regulations such as the FDA in the US, the CE directive in the EU, and other national or international regulatory frameworks.
Establishing quality control systems to monitor IVD kit manufacturing, ensuring compliance with specifications and detecting potential quality issues.
Managing changes throughout the IVD kit lifecycle, documenting changes, assessing their regulatory impact, and implementing them appropriately.
Engaging with competent regulatory authorities to obtain necessary approvals and maintain transparent communication regarding regulatory aspects of the kit.
These services collectively ensure that your IVD diagnostic kit meets regulatory standards, performs effectively, and is brought to market with assurance and adherence to regulations.